Radiopharmaceuticals are a group of pharmaceuticals drug which have radioactivity. It can be used as diagnostic and therapeutic agent. Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical area for diagnosis or therapy.
Global Radiopharmaceuticals Market Report helps businesses to make better choices for future winning planning in terms of current and future trends in particular product or industry.
Get Sample Copy of This Report at- https://databridgemarketresearch.com/request-a-sample/?dbmr=global-radiopharmaceuticals-market
Global Radiopharmaceuticals Market report helps to identify uncertainties that may arise as a result of changes in business activity or the introduction of a new product on the market. It helps businesses take decisive action to address niche market threats.
This report on market research provides comprehensive information on target markets or customers. It also takes into consideration both qualitative and quantitative market analysis techniques. For qualitative analysis, focus groups and in-depth interviews are included, whereas customer survey and secondary data analysis was performed under quantitative analysis.
Global Radiopharmaceuticals Market is expected to reach USD 9.49 billion by 2024 from USD 4.87 billion in 2016, at a CAGR of 8.7% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.
Table of Contents –Analysis of Key Points
1.1. Overview Of The Global Radiopharmaceuticals Market
1.2. Currency And Pricing
1.4. Markets Covered
2 Market Segmentation
2.1. Key Takeaways
2.2. Arriving At The Global Radiopharmaceuticals Size
2.2.1 Vendor Positioning Grid
2.2.2 Technology Life Line Curve
2.2.3 Market Time Line
2.2.4 Market Guide
2.2.5 Company Positioning Grid
2.2.6 Comapany Market Share Analysis
2.2.7 Multivariate Modelling
2.2.8 Standards Of Measurement
2.2.9 Top To Bottom Analysis
2.2.10 Vendor Share Analysis
2.2.11 Data Points From Key Primary Interviews
2.2.12 Data Points From Key Secondary Databases
2.3. Global Radiopharmaceuticals Market: Research Snapshot
3 Market Overview
4 Executive Summary
5 Premium Insights
5.1. Vendor Positioning Grid And Investment Opportunities
5.2. Technololgical Advancements
5.3. Insights On Technological Developments In The Global Radiopharmaceuticalsmarket
5.4. Market Regulatory Scenario By Country
5.5. Interview Key Insights
6 Global Radiopharmaceuticals Market, By Type
7 Global Radiopharmaceuticals Market, By Procedural Volumes
8 Global Radiopharmaceuticals Market, By Application
9 Global Radiopharmaceuticals Market, By Sources
10 Global Radiopharmaceuticals Market, By End-User
11 Global Radiopharmaceuticals Market, By Geography
12 Global Radiopharmaceuticals Market, Company Profiles
12.1 Cardinal Health Inc.,
12.3 Ge Healthcare,
12.4 Lantheus Medical Imaging Inc.,
12.5 Bayer Ag,
12.6 Company A
12.7 Company B
Browse Detailed TOC, Tables, Figures, Charts and Companies Mentioned in Market Research Report at: – https://databridgemarketresearch.com/toc/?dbmr=global-radiopharmaceuticals-market
Key Questions Answered in Radiopharmaceuticals market report:
- What will the market size be in 2024 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
The Leading Major Players Covered in this Report
- Cardinal Health Inc.
- GE Healthcare
- Lantheus Medical Imaging Inc.
- Bayer AG, Bracco Imaging SpA
- Eczacibasi-Monrol Nuclear Products
- Nordion Inc.
- Advanced Accelerator Applications S.A.
- IBA Molecular Imaging
- Positron Corporation
- NTP Radioisotopes Pty. Ltd.
- Advanced Medical Isotope Corporation
- Avid Radiopharmaceuticals
- Jubilant Pharma, Actinium Pharmaceuticals Inc.,
- AREVA Meds,Immunomedics Inc.
- Merck& Co., Inc.
- PETNET Solutions Inc.
- Eckert & Ziegler
- Siemens Healthcare, and Positron Corporation among others
The global market is segmented based on type, procedural volumes, application, sources, end-user,and geography.
On the basis of type, the global radiopharmaceuticals market is sub-segmented into diagnostic and therapeutic radiopharmaceuticals. In 2017, diagnostic radiopharmaceuticals segment dominate the market and is expected to grow at the highest in the forecast period. This is due to the production of MO-99 in the U.S., FDA approvals of radiopharmaceuticals, initiatives of International Atomic Energy Agency (IAEA), new irradiation facility in Germany, installation of PET scanners in India, andgovernment investments in Rest of Asia-Pacific.
On the basis of procedural volumes, the global radiopharmaceuticals market is sub-segmented into diagnostic procedures and therapeutic procedures. Diagnostic procedures are further sub-segmented into single-photon emission computed tomography (SPECT) radiopharmaceuticals and positron emission tomography (PET) radiopharmaceuticals. Therapeutic procedures are further sub-segmented into beta emitters, alpha emitters and brachy therapy.
On the basis of application, the global radiopharmaceuticals market is sub-segmented into diagnostic application and therapeutic application. Diagnostic application are further sub-segmented into single-photon emission computed tomography (SPECT) and positron emission tomography (PET). Single-photon emission computed tomography (SPECT) includes cardiology, lymphoma, thyroid, neurology and others. Positron emission tomography (PET) includes oncology, cardiology, neurology and others. Therapeutic application is further sub-segmented into thyroid, bone metastasis, lymphoma, endocrine tumours and others.
On the basis of sources, the global radiopharmaceuticals market is sub-segmented into nuclear reactors and cyclotrons.
On the basis of end user, the global radiopharmaceuticals market is sub-segmented into hospitals, ambulatory surgical centers, diagnostic centers, cancer research institutesand others. In 2017, hospital segment dominate the market with the highest market share due to accessibility of highly skilled medical practitioners in the radiology departments of hospitals.
Based on geography, the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The geographical regions are further segmented into 29 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and others. In 2017, North America is expected to dominate the radiopharmaceuticals market with more than 42.5%market share with a share of 4.7% followed by Europe and Asia-Pacific. However the Asia-Pacific region is expected to grow at the highest CAGR in the forecast period 2017 to 2024. This can be due to the rising demand of PET scanners and high production of radiopharmaceuticals for therapeutic purposes in India, aging population, rising patient awareness, increasing healthcare expenditure in Japan and China, and initiatives by the Australian government.
About Data Bridge Market Research:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge Market Research